Adicet Bio, Inc.ACET

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$9.02
Market cap
$84.4M
P/E
—
Revenue (TTM)
—
Net income
-$99.0M
Dividend yield
—
1-year total return
-32.8%
Net margin
—
Revenue growth
—
Debt / equity
—

What Adicet Bio, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income-$36.7M-$62.0M-$69.8M-$142.7M-$117.1M-$116.8M
Free cash flow-$42.5M-$64.1M-$61.5M-$98.2M-$93.5M-$97.0M

More on ACET.

Figures from Adicet Bio, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.